| Original document(33 pages) 中文版 |
The invention relates to compounds of formula (I), wherein W is an oxygen or sulphur atom, each X, X2, X3 and X4 independently represents a hydrogen or halogen atom or a cyano, C,-C6-alkyl, C,-C6-fluoralkyl, C,-C6-alkoxy, C,-C6-fluoroalkoxy group, Y is in position (N2) or (N3); when Y is in the (N2) position, Y represents a C,-C6-alkyl, C,-C6-fluoralkyl, aryl or heteroaryl group; when Y is in the (N3) position, Y represents an aryl or heteroaryl group; the aryl and heteroaryl groups are possibly substituted by one or several atoms or groups selected from halogen atoms, C,-C6-alkyl, C,-C6-alkoxy, C,-C6-alkylthio, C,-C6-alkyl-S(O)-, C,-C6-alkyl-S(0)2-, C,-C6-fluoralkyl groups; a C4-C5 position bond is double or single; each R1 et R2 independently represents an aryl, benzyl or C,-C6-alkyl group or R1 et R2 form, with a nitrogen atom carrier thereof, a heterocycle possibly substituted by one or several C1-C6-alkyl or benzyl groups in the form of a base, an acid addition salt, a hydrate or a solvate. A method for preparation and therapeutic use is also disclosed. |
Application Number
申请号 |
200580007686 |
Application Date
申请日 |
2005.05.10 |
| Title 名称 |
2H- or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
Publication Number
公开号 |
1930131 |
Publication Date
公开日 |
2007.03.14 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
C07D231/54 |
Applicant(s) Name
申请人 |
Sanofi Aventis |
| Address 地址 |
|
| Inventor(s) Name 发明人 |
|
| Attorney & Agent 代理人 |
liuwei sheng linsen |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|